News

This two-year Phase II grant, awarded through the Small Business Innovation Research (SBIR) program of the National Science Foundation, will support studies focused on the synthesis and testing

The company has granted a 30-day option to the underwriters to purchase up to an additional 15% of the offering to cover over-allotments, and the underwriters have exercised

The parties will conduct large scale genetic studies on samples from hundreds of patients with HCV who have been treated, successfully and unsuccessfully, with interferon alfa and ribavirin,

The funds were used to acquire Diabetic Plus – a diabetic supply mail-order distributor based in Sunrise, Florida – and to provide working capital for growth. The $4

FAST1 is said to be the most rapid, reliable and safe alternative to conventional IV infusion providing lifesaving vascular access for fluid and drug resuscitation in shock and

Under the agreement, Quest Diagnostics has licensed rights to uses of the Septin 9 DNA methylation biomarker to develop a molecular-based laboratory test that can help physicians detect

This enabling patent provides processes to synthesize compounds that would otherwise be difficult and expensive to prepare with high purity and steroselectivity. These compounds are the lead drugs

As per the new FDA guidelines, the organization which publishes the articles must contain an editorial board. The organization should also fully disclose any conflicts of interest or

The Center claimed that the pace and development of pharmaceutical companies in the future would largely depend on strategic alliances and partnerships they forge in their R&D activities.